Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures.
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer treated primarily with chemotherapy, but current regim...
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer treated primarily with chemotherapy, but current regim...
This study reports the development and validation of a non-invasive circulating cell-free DNA (cfDNA)-based model for ea...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis, primarily due to late diagnos...
The study (DOI: 10.1002/ijc.70142) developed and validated a preoperative prediction model for early postoperative recur...